Lung Disease
-
Third Clinical Year in Review Session Spotlights Key Advances in ILD, Lung Transplant, and More
on
Read more: Third Clinical Year in Review Session Spotlights Key Advances in ILD, Lung Transplant, and MoreThe third ATS 2026 International Conference Clinical Year in Review session on Tuesday, May 19, featured experts discussing updates to guidelines and impactful studies in cystic fibrosis and non-CF bronchiectasis, interstitial lung disease, lung transplant, and environmental lung diseases.
-
Final Clinical Year in Review Session Shares State-of-the-Art Science in COPD, Interventional Pulmonary Medicine, Medical Education, and Lung Cancer
on
Read more: Final Clinical Year in Review Session Shares State-of-the-Art Science in COPD, Interventional Pulmonary Medicine, Medical Education, and Lung CancerThe ATS 2026 Orlando Clinical Year in Review series concluded on Wednesday, May 20, with an expert-curated summary of recent advances across the clinical care continuum in COPD, interventional pulmonary medicine, medical education, and lung cancer.
-
Investigators Debut Data from Breaking Clinical Trials in Pulmonary Medicine
on
Read more: Investigators Debut Data from Breaking Clinical Trials in Pulmonary MedicineResearchers shared results from four impactful clinical trials for the first time during “Breaking News: Clinical Trial Results in Pulmonary Medicine” on Sunday at ATS 2026 Orlando. The studies offered insights into pulmonary arterial hypertension, idiopathic pulmonary fibrosis, obstructive sleep apnea, and more.
-
PAR Symposium Tackles New Approaches for Treating Patients with Chronic Cough
on
Read more: PAR Symposium Tackles New Approaches for Treating Patients with Chronic CoughThe “PAR Symposium: New Approaches to the Patient with Chronic Productive Cough” at ATS 2026 Orlando will be held from 9:15–10:45 a.m. on Tuesday. Session Chair Siri Vaeth, MSW, shared that the symposium will address the diverse causes of chronic coughs, physical and mental health symptoms that can accompany the condition, best practices for treatment,…
-
Scientific Symposium Spotlights Understudied Aspects of Health Disparities and Social Determinants of Health
on
Read more: Scientific Symposium Spotlights Understudied Aspects of Health Disparities and Social Determinants of HealthAt 9:15 a.m. on Tuesday, the symposium, “Global Disparities and Social Determinants: Innovative Interventions for Lung Health,” will spotlight best practices for race-neutral spirometry evaluations, analyze the effects of climate change on certain neighborhoods, and more. Session Chair Dawn L. Demeo, MD, MPH, previewed the symposium with ATS Conference News.
-
Final Clinical Year in Review Sessions Distill Impactful Data Into Pragmatic Strategies
on
Read more: Final Clinical Year in Review Sessions Distill Impactful Data Into Pragmatic StrategiesThis year’s Clinical Year in Review presentations will cover precision approaches that incorporate biologics, endotypes risk scores, and optimal treat-to-target strategies. Ayodeji Adegunsoye, MD, PhD, MSc, series co-chair, said the aim is to empower clinicians with critical, timely information that positively affects patients’ disease trajectory. The final sessions will be held from 9:15–10:45 a.m. on…
-
PAR Forum Spotlights the Patient Voice in Lung Health Research
on
Read more: PAR Forum Spotlights the Patient Voice in Lung Health ResearchSpeakers emphasized the crucial role of patient advocacy in shaping lung health research and policy at the ATS Public Advisory Roundtable Patients & Experts Forum on Saturday morning. The forum focused on drug repurposing and complementary therapies, uniting clinicians, researchers, and patient advocates.
-
Trudeau Medalist Recounts the Challenges and Rewards of a Career Studying Human Lung Mechanics
on
Read more: Trudeau Medalist Recounts the Challenges and Rewards of a Career Studying Human Lung MechanicsCharles G. Irvin, PhD, ATSF, is this year’s recipient of the ATS Edward Livingston Trudeau Medal, the highest honor bestowed by the Society. Dr. Irvin spoke with ATS Conference News to discuss his career and lifelong focus on the mechanical and cellular dysfunction underlying airway diseases.
-
Amberson Lecturer Discusses Lessons Learned and Future Approaches to Regenerating Lung Homeostasis
on
Read more: Amberson Lecturer Discusses Lessons Learned and Future Approaches to Regenerating Lung HomeostasisMarc Peters-Golden, MD, will present the J. Burns Amberson Lecture at 4:30 p.m. on Sunday. Speaking with ATS Conference News, Dr. Peters-Golden looked back on his professional journey and looked ahead to future-facing cyclic AMP therapies.
-
ATS 2026 Orlando Program Aims to Maintain Momentum from Recent Breakthroughs in ILD and IPF
on
Read more: ATS 2026 Orlando Program Aims to Maintain Momentum from Recent Breakthroughs in ILD and IPFThe ATS 2026 International Conference will spotlight a wide range of recent investigative and clinical advances in the treatment of interstitial lung disease (ILD) and idiopathic pulmonary fibrosis (IPF), including the development of nerandomilast, the first FDA-approved therapy for IPF in over a decade. Susan K. Mathai, MD, spoke with ATS Conference News to preview…